Search results for "AFE"

showing 10 items of 2733 documents

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference

2020

Proper trial design is critical for the success of clinical investigations. Hepatocellular carcinoma (HCC) is a complex disease that has several unique properties. In 2008, after the approval of sorafenib, a panel of experts proposed guidelines for trial design and endpoints in HCC that have been instrumental during the last decade and provided a framework to allow an homogeneous analysis of reported investigations. Since then, several phase III studies have been reported and novel challenges have emerged. A panel of experts conveyed by AASLD organized a Special Topic Conference on trial design and endpoints to address those emerging challenges. This review summarizes the analysis and concl…

0301 basic medicineSorafenibmedicine.medical_specialtyCarcinoma HepatocellularConsensusEndpoint DeterminationMEDLINEDisease03 medical and health sciences0302 clinical medicinemedicineHumansProgression-free survivalChemoembolization TherapeuticLiquid biopsyIntensive care medicineAdverse effectImmune Checkpoint InhibitorsProtein Kinase InhibitorsClinical Trials as TopicHepatologybusiness.industryLiver NeoplasmsLiquid Biopsymedicine.diseaseLiver TransplantationClinical trial030104 developmental biologyResearch DesignHepatocellular carcinoma030211 gastroenterology & hepatologybusinessmedicine.drugHepatology
researchProduct

VISMapper: ultra-fast exhaustive cartography of viral insertion sites for gene therapy

2017

The possibility of integrating viral vectors to become a persistent part of the host genome makes them a crucial element of clinical gene therapy. However, viral integration has associated risks, such as the unintentional activation of oncogenes that can result in cancer. Therefore, the analysis of integration sites of retroviral vectors is a crucial step in developing safer vectors for therapeutic use. Here we present VISMapper, a vector integration site analysis web server, to analyze next-generation sequencing data for retroviral vector integration sites. VISMapper can be found at: http://vismapper.babelomics.org . Because it uses novel mapping algorithms VISMapper is remarkably faster t…

0301 basic medicineWeb serverVirus IntegrationGenetic enhancementGenetic VectorsContext (language use)Computational biologyBiologyGenoma humàlcsh:Computer applications to medicine. Medical informaticscomputer.software_genreBiochemistryGenome viewerViral vectorViral integrationUser-Computer Interface03 medical and health sciencesGene therapyStructural BiologySAFERViral insertionSequence mappingHumansUltra fastGens Mapatgelcsh:QH301-705.5Molecular BiologyGeneticsInternetBase SequenceApplied MathematicsHigh-Throughput Nucleotide SequencingGenetic Therapy3. Good healthComputer Science Applications030104 developmental biologylcsh:Biology (General)lcsh:R858-859.7Viral integrationDNA microarraycomputerSoftware
researchProduct

Development of a method for the direct fermentation of semolina by selected sourdough lactic acid bacteria

2016

Three obligately heterofermentative lactic acid bacteria (LAB) strains (Lactobacillus sanfranciscensis PON100336, Leuconostoc citreum PON10079 and Weissella cibaria PON10030) were used in this study as a multi-species starter culture for sourdough production. The starter inoculum was prepared and propagated in sterile semolina extract (SSE) broth. Acidification kinetics, microbiological counts detected on specific media for sourdough LAB, polymorphic profile comparison and species-specific PCRs evidenced a stability of the liquid inoculum over time determining its suitability for direct addition to semolina. In order to validate this innovative method for the production of durum wheat (Trit…

0301 basic medicineWeissellaFlour030106 microbiologyLactobacillus sanfranciscensisFermentation; Lactic acid bacteria; Quality parameters; Sourdough; Starter culture; Triticum durum genotypes; Volatile organic compounds; Microbiology; Food Science; Safety Risk Reliability and Qualitymedicine.disease_causePolymerase Chain ReactionMicrobiology03 medical and health sciencesStarterLeuconostoc citreumLactobacillusLactic acid bacteriamedicineLeuconostocLactic AcidFood scienceWeissella cibariaSafety Risk Reliability and QualityTriticumbiologyChemistryfood and beveragesBreadSettore AGR/15 - Scienze E Tecnologie AlimentariGeneral MedicineVolatile organic compoundbiology.organism_classificationTriticum durum genotypeSettore AGR/02 - Agronomia E Coltivazioni ErbaceeQuality parameterLactobacillusStarter culture030104 developmental biologyItalyWeissellaSourdoughFermentationFermentationLeuconostocSettore AGR/16 - Microbiologia AgrariaFood ScienceInternational Journal of Food Microbiology
researchProduct

Fatty Acid Composition of Gluten-Free Food (Bakery Products) for Celiac People

2018

The aim of this study (first analytical approach) was to obtain data concerning the fatty acid composition of gluten-free foods (bakery products) for celiac people. The study included 35 different products (snacks, biscuits, bakery products, pasta, flours, etc.) from several manufacturers. After extraction and esterification, the fatty acid composition was determined by Gaschromatography (GC&ndash

0301 basic medicineanalytical_chemistryHealth (social science)celiacPlant ScienceRaw materiallcsh:Chemical technologyHealth Professions (miscellaneous)Microbiologyfatty acidsArticle03 medical and health sciencesPalm kernellcsh:TP1-1185GC–MSFood sciencechemistry.chemical_classification030109 nutrition & dieteticsbusiness.industryChemistryfood and beveragesFood safetyGluten-free foods030104 developmental biologyGluten freeFatty acid compositionGas chromatography–mass spectrometrybusinessFood SciencePolyunsaturated fatty acidOlive oilgluten-free foods
researchProduct

Results of COLUMBUS Part 2: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus ENCO in BRAF-mutant melanoma

2017

0301 basic medicinebusiness.industryMelanomaMutantBinimetinibHematologymedicine.disease03 medical and health scienceschemistry.chemical_compound030104 developmental biology0302 clinical medicineOncologychemistry030220 oncology & carcinogenesisEncorafenibmedicineCancer researchbusiness
researchProduct

Statins in liver disease: not only prevention of cardiovascular events

2018

Statins are lipid-lowering agents and one of the most pre-scribed drugs worldwide. Their main mechanism of action –inhibition of the mevalonate pathway through an effect on hydroxy-methylglutaryl CoA reductase, thus affecting the synthesis of cholesterol in the liver – makes this class of drugs pivotal in primary and secondary prevention of cardio-vascular risk, as extensively demonstrated in large prospective, randomized controlled trials. Along the years, we learned that the lower the better, and LDL-cholesterol targets have been progressively reduced to values ≤70 mg/dL for secondary prevention or in the presence of diabetes.

0301 basic medicinecardiovascular riskmedicine.medical_specialtydrug safetyGastroenterology03 medical and health sciencesLiver disease0302 clinical medicineInternal medicineFatty livermedicineHumansHypolipidemic AgentsHepatologybusiness.industryFatty liverhydroxymethylglutaryl-CoA reductase inhibitorGastroenterologynon-alcoholic fatty liver diseaseHepatologymedicine.diseaseHydroxymethylglutaryl-CoA Reductase Inhibitors030104 developmental biologyCardiovascular DiseasesDisease Progressionlipids (amino acids peptides and proteins)030211 gastroenterology & hepatologyHydroxymethylglutaryl-CoA Reductase Inhibitorsbusiness
researchProduct

New 3-Aryl-2-(2-Thienyl)acrylonitriles with High Activity against Hepatoma Cells

2021

New 2-(thien-2-yl)-acrylonitriles with putative kinase inhibitory activity were prepared and tested for their antineoplastic efficacy in hepatoma models. Four out of the 14 derivatives were shown to inhibit hepatoma cell proliferation at (sub-)micromolar concentrations with IC50 values below that of the clinically relevant multikinase inhibitor sorafenib, which served as a reference. Colony formation assays as well as primary in vivo examinations of hepatoma tumors grown on the chorioallantoic membrane of fertilized chicken eggs (CAM assay) confirmed the excellent antineoplastic efficacy of the new derivatives. Their mode of action included an induction of apoptotic capsase-3 activity, whil…

0301 basic medicinelcsh:Chemistry0302 clinical medicinelcsh:QH301-705.5SpectroscopyMolecular StructureKinaseChemistryLiver NeoplasmsGeneral MedicineHep G2 CellshepatomaComputer Science ApplicationsCAM assayMolecular Docking SimulationChorioallantoic membraneBiochemistry030220 oncology & carcinogenesistyrphostinTyrosine kinasemedicine.drugSorafenibCarcinoma HepatocellularthiopheneThiophenesCatalysisArticleInorganic ChemistryVEGFR inhibition03 medical and health sciencesStructure-Activity RelationshipIn vivomedicineHumansPhysical and Theoretical ChemistryMode of actionMolecular BiologyProtein Kinase InhibitorsCell ProliferationAcrylonitrileDose-Response Relationship DrugOrganic Chemistrymolecular dockingVascular Endothelial Growth Factor Receptor-2anticancer drugs030104 developmental biologylcsh:Biology (General)lcsh:QD1-999ApoptosisDocking (molecular)Drug Screening Assays AntitumorInternational Journal of Molecular Sciences
researchProduct

Caenorhabditis elegans as an in vivo model to assess fucoidan bioactivity preventing Helicobacter pylori infection

2020

Currently, Helicobacter pylori is the unique biological carcinogenic agent. The search for antimicrobial alternatives to antibiotics against this pathogen has been categorized as a priority due to the drastic failure associated with current applied antibiotic therapy. The present study assessed the bioactive antimicrobial capability of fucoidan (“Generally Recognized as Safe” approval – European Commission December 2017) from different species of Phaeophyceae algae (Fucus vesiculosus, Undaria pinnatifida, Macrocystis pyrifera) against H. pylori. All the studied fucoidans showed bacteriostatic and bactericidal effects at the studied concentrations [5–100] μg ml−1 and exposure times [0–7 days…

0301 basic medicinemedicine.drug_classAntibioticsPhaeophytaMicrobiologyHelicobacter Infections03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNutraceuticalAnti-Infective AgentsIn vivoPolysaccharidesGenerally recognized as safemedicineAnimalsCaenorhabditis elegansPathogenbiologyHelicobacter pyloriFucoidanGeneral MedicineHelicobacter pyloribiology.organism_classificationAntimicrobial3. Good healthDisease Models Animal030104 developmental biologychemistry030220 oncology & carcinogenesisFood Science
researchProduct

Prevalence of Listeria spp. and characterization of Listeria monocytogenes isolated from food products in Tetouan, Morocco

2018

A total of 1096 food samples were purchased in Tetouan, North-Western of Morocco, to examine the presence of Listeria spp. Eighty (7.3%) of the tested samples were found positive for the presence of Listeria spp., while L. monocytogenes was detected in 16 (1.5%) samples. L. monocytogenes isolates belonged to clonal complexes CC2 (PCR serogroup IVb) and CC199 (PCR serogroup Ila) and to 8 different combined AscI/Apal pulsed-field gel electrophoresis profiles. Core genome multilocus sequence typing (cgMLST) allowed to distinguish 12 different cgMLST types and revealed the presence of 3 clusters of closely-related isolates from different samples, suggesting the existence of common sources of co…

0301 basic medicinemedicine.drug_classListeriaPCR-Serogrouping030106 microbiologyAntibioticsPrevalenceBiologymedicine.disease_causeMicrobiology03 medical and health sciencesListeria monocytogenes[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesmedicineComputingMilieux_MISCELLANEOUS2. Zero hungerGel electrophoresisbusiness.industryPFGEbiology.organism_classificationFood safety[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyMorocco030104 developmental biology[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyFood productsListeriaMultilocus sequence typingcgMLSTbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyFood ScienceBiotechnology
researchProduct

RE: Regorafenib Also Can Cause Osteonecrosis of the Jaw

2016

0301 basic medicinemedicine.medical_specialtyCancer Researchbusiness.industryMedicine (all)Medicine (all); Oncology; Cancer Researchmedicine.diseaseSurgery03 medical and health scienceschemistry.chemical_compound030104 developmental biology0302 clinical medicinechemistryOncology030220 oncology & carcinogenesisRegorafenibmedicineRegorafenib Osteonecrosis of the JawOsteonecrosis of the jawbusiness
researchProduct